Skip to Content

BNY Mellon International Equity A NIEAX

Medalist Rating as of | See BNY Mellon Investment Hub
  • NAV / 1-Day Return 22.29  /  +0.50 %
  • Total Assets 324.1 Mil
  • Adj. Expense Ratio
    1.070%
  • Expense Ratio 1.070%
  • Distribution Fee Level Below Average
  • Share Class Type Front Load
  • Category Foreign Large Blend
  • Investment Style Large Growth
  • Min. Initial Investment 1,000
  • Status Closed
  • TTM Yield 1.80%
  • Turnover 46%

USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:19 PM GMT+0

Morningstar’s Analysis NIEAX

Will NIEAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Strength in BNY Mellon International Equity A's Process Pillar is partially offset by an Average People Pillar rating, leading to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings NIEAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 28.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Nestle SA

3.85 12.4 Mil
Consumer Defensive

ASML Holding NV

3.67 11.8 Mil
Technology

Novo Nordisk A/S Class B

3.10 9.9 Mil
Healthcare

Novartis AG Registered Shares

2.94 9.4 Mil
Healthcare

Lvmh Moet Hennessy Louis Vuitton SE

2.93 9.4 Mil
Consumer Cyclical

SAP SE

2.79 9.0 Mil
Technology

AstraZeneca PLC

2.65 8.5 Mil
Healthcare

RELX PLC

2.37 7.6 Mil
Industrials

Sanofi SA

2.26 7.3 Mil
Healthcare

Wolters Kluwer NV

2.22 7.1 Mil
Industrials